產(chǎn)品詳情
簡單介紹：
Anti-C1orf51抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-C1orf51抗體用于**組化實驗,WB實驗,相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-C1orf51
Cat. Number:
Anti-C1orf51抗體KL-9786R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Chromosome 1 is the largest human chromosome spanning about 260 million base pairs and making up 8% of the human genome. There are about 3,000 genes on chromosome 1, and considering the great number of genes there are also a large number of diseases associated with chromosome 1. Notably, Anti-C1orf51抗體the rare aging disease Hutchinson-Gilford progeria is associated with the LMNA gene which encodes lamin A. When defective, the LMNA gene product can build up in the nucleus and cause characteristic nuclear blebs. The mechanism of rapidly enhanced aging is unclear and is a topic of continuing exploration. The MUTYH gene is located on chromosome 1 and is partially responsible for familial adenomatous polyposis. Stickler syndrome, Parkinsons, Gaucher disease and Usher syndrome are also associated with chromosome 1. A breakpoint has been identified in 1q which disrupts the DISC1 gene and is linked to schizophrenia. Aberrations in chromosome 1 are found in a variety of cancers including head and neck cancer, malignant melanoma and multiple myeloma. The C1orf51 gene product has been provisionally designated C1orf51 pending further characterization. There are two isoforms of C1orf51 that are produced as a result of alternative splicing events.
Also known as:
C1orf51; CA051_HUMAN;Anti-C1orf51抗體 FLJ25889; Uncharacterized protein C1orf51.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, .
●
Immunogen: KLH conjugated synthetic peptide derived from human C1orf51.
●
Predicted Molecular Weight: 41kDa.
Storage:
Shipped at 4℃, Anti-C1orf51抗體Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
Not yet tested in other applications.
Optimal workingAnti-C1orf51抗體 dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal workingAnti-C1orf51抗體 dilutions must be determined by the end user.
kl626Ra02 胱天蛋白酶3(CASP3)多克隆抗體 Polyclonal Antibody to Caskle 3 (CASP3)
kl672Hu02 Slit同源物2(Slit2)多克隆抗體 Polyclonal Antibody to Slit Homolog 2 (Slit2)
kl692Mu02 神經(jīng)纖維網(wǎng)蛋白1(NRP1)多克隆抗體 Polyclonal Antibody to Neuropilin 1 (NRP1)
kl692Mu03 神經(jīng)纖維網(wǎng)蛋白1(NRP1)多克隆抗體 Polyclonal Antibody to Neuropilin 1 (NRP1)
kl692Mu04 神經(jīng)纖維網(wǎng)蛋白1(NRP1)多克隆抗體 Polyclonal Antibody to Neuropilin 1 (NRP1)
kl711Hu02 肝素酶(HPA)多克隆抗體 Polyclonal Antibody to Heklanase (HPA)
kl775Mu02 己糖激酶1(HK1)多克隆抗體 Polyclonal Antibody to Hexokinase 1 (HK1)
kl775Mu03 己糖激酶1(HK1)多克隆抗體 Polyclonal Antibody to Hexokinase 1 (HK1)
kl820Mu02 凝血因子Ⅱ(F2)多克隆抗體 Polyclonal Antibody to Coagulation Factor II (F2)
kl820Ra02 凝血因子Ⅱ(F2)多克隆抗體 Polyclonal Antibody to Coagulation Factor II (F2)
kl837Mu02 誘導(dǎo)型一氧化氮合酶(NOS2)多克隆抗體 Polyclonal Antibody to Nitric Oxide Synthase 2, Inducible (NOS2)
kl837Mu03 誘導(dǎo)型一氧化氮合酶(NOS2)多克隆抗體 Polyclonal Antibody to Nitric Oxide Synthase 2, Inducible (NOS2)
kl849Hu02 糖原磷酸化酶L(PYGL)多克隆抗體 Polyclonal Antibody to Glycogen Phosphorylase, Liver (PYGL)
kl895Hu02 胰島素受體(ISR)多克隆抗體 Polyclonal Antibody to Insulin Receptor (ISR)
kl980Hu02 內(nèi)皮糖蛋白(ENG)多克隆抗體 Polyclonal Antibody to Endoglin (ENG)
kl030Mu02 蛋白酪氨酸磷酸酶受體C(PTPRC)多克隆抗體 Polyclonal Antibody to Protein Tyrosine Phosphatase Receptor Type C (PTPRC)
kl041Hu02 玻連蛋白(VTN)多克隆抗體 Polyclonal Antibody to Vitronectin (VTN)
kl074Bo02 多聚**球蛋白受體(PIGR)多克隆抗體 Polyclonal Antibody to Polymeric Immunoglobulin Receptor (PIGR)
kl074Bo03 多聚**球蛋白受體(PIGR)多克隆抗體 Polyclonal Antibody to Polymeric Immunoglobulin Receptor (PIGR)
kl074Hu02 多聚**球蛋白受體(PIGR)多克隆抗體 Polyclonal Antibody to Polymeric Immunoglobulin Receptor (PIGR)
